1. Home
  2. MHH vs ADAG Comparison

MHH vs ADAG Comparison

Compare MHH & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

N/A

Current Price

$6.26

Market Cap

81.7M

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

BUY

Current Price

$3.80

Market Cap

146.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MHH
ADAG
Founded
1986
2011
Country
United States
China
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7M
146.3M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MHH
ADAG
Price
$6.26
$3.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
15.5K
184.4K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
145.90
N/A
EPS
N/A
N/A
Revenue
$198,943,000.00
N/A
Revenue This Year
$2.93
$3,688.61
Revenue Next Year
$8.93
$17.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$1.33
52 Week High
$10.91
$4.58

Technical Indicators

Market Signals
Indicator
MHH
ADAG
Relative Strength Index (RSI) 45.43 68.83
Support Level $5.51 $1.64
Resistance Level $7.75 N/A
Average True Range (ATR) 0.37 0.36
MACD 0.04 0.03
Stochastic Oscillator 65.09 51.13

Price Performance

Historical Comparison
MHH
ADAG

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: